-
11.
公开(公告)号:US08026256B2
公开(公告)日:2011-09-27
申请号:US11258980
申请日:2005-10-26
IPC分类号: C07D217/00 , A61K31/47
CPC分类号: C07D231/56 , C07D217/02 , C07D401/12 , C07D403/12
摘要: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
摘要翻译: 式(I)化合物是可用于治疗疼痛,炎性热痛觉过敏,尿失禁或膀胱过度活动的新型VR1拮抗剂。
-
12.Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor 审中-公开
标题翻译: 融合的氮杂双环化合物抑制香草素受体亚型1(VR1)受体公开(公告)号:US20050113576A1
公开(公告)日:2005-05-26
申请号:US10911019
申请日:2004-08-04
申请人: Chih-Hung Lee , Erol Bayburt , Stanley DiDomenico , Irene Drizin , Arthur Gomtsyan , John Koenig , Richard Perner , Robert Schmidt , Sean Turner , Tammie Jinkerson , Guo Zheng
发明人: Chih-Hung Lee , Erol Bayburt , Stanley DiDomenico , Irene Drizin , Arthur Gomtsyan , John Koenig , Richard Perner , Robert Schmidt , Sean Turner , Tammie Jinkerson , Guo Zheng
IPC分类号: C07D209/08 , C07D217/02 , C07D217/22 , C07D231/56 , C07D265/30 , C07D487/08 , C07D43/02
CPC分类号: C07D217/02 , C07D209/08 , C07D217/22 , C07D231/56 , C07D265/30 , C07D487/08
摘要: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
摘要翻译: 式(I)化合物是可用于治疗疼痛,炎性热痛觉过敏,尿失禁和膀胱过度活动的新型VR1拮抗剂。
-
13.Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor 有权
标题翻译: 抑制香草素受体亚型1(VR1)受体的融合化合物公开(公告)号:US20050043351A1
公开(公告)日:2005-02-24
申请号:US10864068
申请日:2004-06-09
申请人: Arthur Gomtsyan , Erol Bayburt , Chih-Hung Lee , John Koenig , Robert Schmidt , Kirill Lukin , Margaret Hsu , Marvin Leanna , Russell Cink , Gilles Chambournier
发明人: Arthur Gomtsyan , Erol Bayburt , Chih-Hung Lee , John Koenig , Robert Schmidt , Kirill Lukin , Margaret Hsu , Marvin Leanna , Russell Cink , Gilles Chambournier
IPC分类号: A61K31/47 , C07D217/12
CPC分类号: C07D217/02 , C07D231/56 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/12 , C07D417/12 , C07D471/08
摘要: The present invention discloses novel compounds of general formula (I) or a pharmaceutically acceptable salt or prodrug thereof (in which X1—X5, R5—R8b, Z1-Z2 and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain in mammals, and pharmaceutical compositions including those compounds and a process for making those compounds.
摘要翻译: 本发明公开了通式(I)的新化合物或其药学上可接受的盐或前药(其中X1-X5,R5-R8b,Z1-Z2和Ar1如本文所定义),哺乳动物中抑制VR1受体的方法 使用这些化合物,控制哺乳动物疼痛的方法,以及包含那些化合物的药物组合物和制备这些化合物的方法。
-
14.Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof 有权
标题翻译: 香草素受体亚型1(VR1)的拮抗剂及其用途公开(公告)号:US07902236B2
公开(公告)日:2011-03-08
申请号:US12365643
申请日:2009-02-04
申请人: Arthur Gomtsyan , Richard J. Perner , John R. Koenig , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Chih-Hung Lee
发明人: Arthur Gomtsyan , Richard J. Perner , John R. Koenig , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Chih-Hung Lee
IPC分类号: A61K31/426 , A61K31/421
CPC分类号: C07D263/48
摘要: The present invention is directed to compounds of formula (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.
摘要翻译: 本发明涉及式(I)化合物,其中变量W,X,Y,D,A,n,R 1,R 2和R 9如说明书中所定义。
-
15.Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors 有权
标题翻译: 抑制P2X3和P2X2 / 3受体的芴和蒽公开(公告)号:US06693136B1
公开(公告)日:2004-02-17
申请号:US10206265
申请日:2002-07-26
申请人: Chih-Hung Lee , Meiqun Jiang , Richard A. Perner , Arthur Gomtsyan , Erol K. Bayburt , Guo Zhu Zheng
发明人: Chih-Hung Lee , Meiqun Jiang , Richard A. Perner , Arthur Gomtsyan , Erol K. Bayburt , Guo Zhu Zheng
IPC分类号: A61K3118
CPC分类号: C07C311/21 , C07C311/29 , C07C2603/18 , C07C2603/24
摘要: Compounds of formula (I) are novel P2X3 and P2X2/P2X3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.
摘要翻译: 式(I)化合物是新型P2X3和P2X2 / P2X3受体拮抗剂,可用于治疗疼痛,尿失禁和膀胱过度活动。
-
16.ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USE THEREOF 有权
标题翻译: VANILLOID受体亚型1(VR1)的拮抗剂及其用途公开(公告)号:US20100010055A1
公开(公告)日:2010-01-14
申请号:US12365643
申请日:2009-02-04
申请人: Arthur Gomtsyan , Richard J. Perner , John R. Koenig , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Chih-Hung Lee
发明人: Arthur Gomtsyan , Richard J. Perner , John R. Koenig , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Chih-Hung Lee
IPC分类号: A61K31/426 , A61K31/421 , A61P29/00 , A61P13/00
CPC分类号: C07D263/48
摘要: The present invention is directed to compounds of formula (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.
摘要翻译: 本发明涉及式(I)化合物,其中变量W,X,Y,D,A,n,R 1,R 2和R 9如说明书中所定义。
-
17.Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Uses Thereof 有权
标题翻译: Vanillaid受体亚型1(VR1)的拮抗剂及其用途公开(公告)号:US20070249614A1
公开(公告)日:2007-10-25
申请号:US11735074
申请日:2007-04-13
申请人: Brian Brown , John Koenig , Arthur Gomtsyan , Chih-Hung Lee
发明人: Brian Brown , John Koenig , Arthur Gomtsyan , Chih-Hung Lee
IPC分类号: A61K31/519 , A61K31/4747 , C07D498/10
CPC分类号: C07D491/107 , C07D405/12 , C07D493/10
摘要: The present invention is directed to compounds of formula (I) wherein variables X1, X2, Y, R1a, R1b, R2a, R2b, A1, A2, A3, and A4 are as defined in the description, and methods of use to treat pain, neuropathic pain, allodynia, pain associated with inflammation or an inflammatory disease, inflammatory hyperalgesia, bladder overactivity, and urinary incontinence.
摘要翻译: 本发明涉及式(I)的化合物,其中变量X 1,X 2,Y,R 1a,R I, R 1b,R 2a,R 2b,A 1,A 2,A 2, 3和A 4如定义在描述中,以及用于治疗疼痛,神经性疼痛,异常性疼痛,与炎症或炎性疾病相关的疼痛,炎性痛觉过敏,膀胱过度活动 和尿失禁。
-
18.Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof 有权
标题翻译: 香草素受体亚型1(VR1)的拮抗剂及其应用公开(公告)号:US20060281799A1
公开(公告)日:2006-12-14
申请号:US11431459
申请日:2006-05-10
申请人: Arthur Gomtsyan , Richard Perner , John Koenig , Margaret Hsu , Dilinie Fernando , Chih-Hung Lee
发明人: Arthur Gomtsyan , Richard Perner , John Koenig , Margaret Hsu , Dilinie Fernando , Chih-Hung Lee
IPC分类号: A61K31/421 , C07D263/02
CPC分类号: C07D263/48
摘要: The present invention is directed to compounds of formula (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.
摘要翻译: 本发明涉及式(I)的化合物,其中变量W,X,Y,D,A,n,R 1,R 2和R 2, 9 SUB>如说明书中所定义。
-
19.Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof 有权
标题翻译: 抑制香草素受体亚型1(VR1)的噻吩并吡啶基化合物及其用途公开(公告)号:US20060148843A1
公开(公告)日:2006-07-06
申请号:US11293012
申请日:2005-12-02
申请人: Sean Turner , Tammie Jinkerson , Arthur Gomtsyan , Chih-Hung Lee
发明人: Sean Turner , Tammie Jinkerson , Arthur Gomtsyan , Chih-Hung Lee
IPC分类号: A61K31/4743 , C07D498/02
CPC分类号: C07D495/04 , C07D498/04
摘要: The present invention discloses fused thienopyridyl compounds of general formula (I) wherein X1-X6, R5-R7, Z1 and L are as defined in the description. The resent invention also discloses a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain, urinary incontinence, bladder overactivity, and inflammatory thermal hyperalgesia in mammals, and pharmaceutical compositions including those compounds.
摘要翻译: 本发明公开了通式(I)的稠合噻吩并吡啶基化合物,其中X 1 -X 6 -X 6,R 5 -R 7, / SUB,Z 1和L如说明书中所定义。 本发明还公开了使用这些化合物抑制哺乳动物中的VR1受体的方法,用于控制哺乳动物中的疼痛,尿失禁,膀胱过度活动和炎性热痛觉过敏的方法,以及包括那些化合物的药物组合物。
-
20.
公开(公告)号:US07015233B2
公开(公告)日:2006-03-21
申请号:US10459925
申请日:2003-06-12
IPC分类号: C07D217/00 , A61K31/47
CPC分类号: C07D231/56 , C07D217/02 , C07D401/12 , C07D403/12
摘要: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.
摘要翻译: 式(I)化合物是可用于治疗疼痛,炎性热痛觉过敏,尿失禁或膀胱过度活动的新型VR1拮抗剂。
-
-
-
-
-
-
-
-
-